Drug Type Small molecule drug |
Synonyms Vonoprazan Fumarate/Amoxicillin Hydrate/Metronidazole, Vonoprazan Fumarate/amoxicillin/Metronidazole, Vonopion + [1] |
Action modulators, inhibitors |
Mechanism DNA modulators(DNA modulators), P-CAB(Potassium-competitive acid blockers), PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Feb 2016), |
Regulation- |
Molecular FormulaC16H21N3O6S |
InChIKeyAIPFZZHNBUVELL-YWUHCJSESA-N |
CAS Registry61336-70-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Duodenal Ulcer | Japan | 25 Feb 2016 | |
| Gastritis | Japan | 25 Feb 2016 | |
| Helicobacter pylori infection | Japan | 25 Feb 2016 | |
| Marginal Zone B-Cell Lymphoma | Japan | 25 Feb 2016 | |
| Purpura, Thrombocytopenic, Idiopathic | Japan | 25 Feb 2016 | |
| Stomach Ulcer | Japan | 25 Feb 2016 |





